Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,385 public trials 1,303 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients

NCT02851407

Conditions
Cardiovascular Diseases, Digestive System Diseases, Hepatic Veno-Occlusive Disease, +3 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 114 locations
View Trial Details
Completed

A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma

NCT02178358

Conditions
Adenocarcinoma, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bengbu, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China
View all 16 locations
View Trial Details
Completed

Chimeric Antigen Receptor T Cells Targeting Glypican-3

NCT03884751

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • The 81st Hospital of Chinese PLA Nanjing, Jiangsu, China
  • Renji Hospital Shang Hai Jiaotong Unversity of Medicine Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions